Company profile

Glactone Pharma AB company profile

Glactone Pharma is founded on research that has demonstrated that the natural product galiellalactone can inhibit the growth of prostate cancer cells. With these results as the starting point the company has focused on discovering and developing novel drug-like compounds that display efficacious and selective STAT3 inhibition in vitro and in specific immune-oncology and prostate cancer models.

Business identity

Operating status
Closed
Company type
For Profit
Founded
2012-01-01

Headquarters

Headquarters
Helsingborg, Skane Lan, Sweden
Country code
SE
Continent
Europe

Capital profile

Funding and company signals

Articles
1

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.